PCVX
#990
Vaxcyte, Inc. - Common Stock
59.8 4 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.16%
Changement Mensuel
+13.01%
Evolution sur 6 mois
-0.42%
Changement Annuel
+41.47%
Clôture Précédente
61.1 6
Open
59.8 4
Low
59.8 4
High
59.8 4
Volume
130
Financials
- Market Capitalization 8.9 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.vaxcyte.com
- Headquarter Delaware, United States
- FIGI BBG009PHHPL8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.2
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 961 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.33 USD | -3.46% | -6.47% | +9.53% | +92.11% | 9.34 B USD | ||
| 982 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.84 USD | -0.01% | +0.15% | +1.08% | +106.42% | 9.00 B USD | ||
| 992 |  ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -5.23% | +41.67% | 8.90 B USD | ||
| 1013 |  IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +11.50% | +244.02% | 8.53 B USD |